Categories: News

CBD of Denver Nears Completion of GAAP Audit

Denver, Colorado–(Newsfile Corp. – December 6, 2021) – CBD of Denver, Inc. (OTC Pink: CBDD), a cultivator and distributor of CBD and cannabis flower and a producer of a full line of CBD oil and unique products sold in Switzerland and throughout Europe, is pleased to report it has received what it believes will be the last request for information needed to complete its GAAP audit, which is being conducted by Fruci and Associates (“Fruci”).

The Company contracted Fruci in February 2021. In preparation for its US GAAP audit, the Company also hired a Swiss auditing firm in January 2021 to compile the required information needed to complete the audit. Fruci had a substantial backlog when retained and only began working on CBD of Denver’s over the summer. With diverse operations across the EU, the audit of the Company is more complex than for a traditional US company, requiring much longer to complete.

“We have been told by Fruci that barring any additional information needed, the audit should be done soon,” commented Marcel Gamma, CEO. “It has been very frustrating watching market makers continuously hamper the movement of our stock when operating results and significant milestones have been met by the team. While our initial audit timeline expectations were overly optimistic, we are continuing to move forward with our plans to become fully reporting and move to a senior exchange as soon as we have the completed audit.”

Follow CBDD on Instagram: @SwissCBDTrading @Rockflowr @CBDofDenver_Inc @SwissGreenGrow @RockflowrRetail

CBD of Denver, Inc., Rockflowr GmbH and Swiss Industry Ventures AG are now also on LinkedIn.

About CBD of Denver, Inc.

CBD of Denver, Inc. (OTC Pink: CBDD) a full-line Cultivator, Distributor of CBD and Cannabis flower and a producer of a full line of CBD oil and unique products sold in Switzerland and throughout Europe. CBD of Denver, Inc. is focused on using equity to acquire profitable Swiss assets at attractive valuations to create value for all our shareholders and is driven by a passion to improve lives and strengthen communities by unleashing the full potential of cannabis. Through our Rockflowr brands we have built a very strong European customer base by focusing on top quality products and meaningful customer relationships.

Information contained herein includes forward-looking statements. These statements relate to future events or future financial performance, involving known and unknown risks and you should not place undue reliance on these statements. Any forward-looking statement reflects our current views with respect to future events. We assume no obligation publicly about update or revise these forward-looking statements for any reason.

Contacts:

Nicholas Sprung
nicholas@cbdofdenver.com

Todd McKnight
RedChip Companies
1-800-733-2447
todd@redchip.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/106817

Staff

Recent Posts

Best Testosterone Supplement For Men Over 40 and 50: Testo Prime for Muscle Growth & Libido 2025

If you are male and in your 40's and 50's and feel your testosterone levels…

5 hours ago

The Anxiety Clinic Launches Innovative Approach to Transform Anxiety into Positive Energy

Transforming Anxiety into Positive Energy: A New Approach by The Anxiety ClinicBondi Junction, New South…

9 hours ago

Solace Psychology Announces Expanded Holiday Stress Management and Mental Health Support Services

Embracing Mental Well-Being During the Festive SeasonCarlton North, Australia--(Newsfile Corp. - December 24, 2024) -…

11 hours ago

Strong Natural Diet Pill Over the Counter for 2025 – PhenQ OTC Weight Loss Supplement

If you are researching the strongest over the counter weight loss supplements in 2025 -…

11 hours ago

Fortitude Wellbeing Enhances Mental Health Services with Comprehensive ADHD Assessments

Fortitude Wellbeing Expands Offerings with ADHD AssessmentsSouth Yarra, Australia--(Newsfile Corp. - December 24, 2024) -…

13 hours ago

MedMira receives Health Canada approval for its Multiplo(R) Rapid (TP/HIV) Test for Syphilis and HIV

HALIFAX, NS / ACCESSWIRE / December 24, 2024 / MedMira Inc. (MedMira) (TSXV:MIR) announced today…

14 hours ago